Skip to content

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
Amgen logo
AmgenAMGN
2.8B0.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
400M+100%
Arcus Biosciences logo
Arcus BiosciencesRCUS
400M0.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$31K+10.7%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$182K+8.3%

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.36B+104%
Enterprise value$3.23B+110%
P/S14.5×+9.9×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IDEAYA Biosciences, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IDEAYA Biosciences, Inc.'s common stock?
IDEAYA Biosciences, Inc. (IDYA) reported common stock of $9K in Q1 2026.
How has IDEAYA Biosciences, Inc.'s common stock changed year-over-year?
IDEAYA Biosciences, Inc.'s common stock decreased by 0.0% year-over-year, from $9K to $9K.
What is the long-term trend for IDEAYA Biosciences, Inc.'s common stock?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s common stock has grown at a 24.6% compound annual growth rate (CAGR), from $3K to $9K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).